Extracellular Vesicles from Interferon-γ-primed Human Umbilical Cord Mesenchymal Stromal Cells Reduce Escherichia coli-induced Acute Lung Injury in Rats

Anesthesiology

Volumn 130, Issue 5, 2019, Pages 778-790

  Varkouhi, Amir K ^a   Jerkic, Mirjana ^a   Ormesher, Lindsay ^a   Gagnon, Stéphane ^a   Goyal, Sakshi ^a   Rabani, Razieh ^a   Masterson, Claire ^a   Spring, Chris ^a   Chen, Paul Z ^e   Gu, Frank X ^d   Dos Santos, Claudia C ^a,b   Curley, Gerard F ^a,b,c,f   Laffey, John G ^a,b,c,g  

^a ST MICHAEL'S HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c ST MICHAEL'S HOSPITAL   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

^e UNIVERSITY OF WATERLOO   (Canada)

^f ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

^g NATIONAL UNIVERSITY OF IRELAND   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; GAMMA INTERFERON; ISOFLURANE; KETAMINE; NITRIC OXIDE SYNTHASE; TUMOR NECROSIS FACTOR;

ACUTE LUNG INJURY; ACUTE MONOCYTIC LEUKEMIA CELL LINE; ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIAL OXYGEN TENSION; ARTICLE; BACTERIAL LOAD; BREATHING RATE; BRONCHOALVEOLAR LAVAGE FLUID; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE SEVERITY; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTION; EXOSOME; HUMAN; HUMAN CELL; IN VITRO STUDY; INJURY SEVERITY; LABORATORY TEST; LUNG LAVAGE; MACROPHAGE; MALE; MESENCHYMAL STROMA CELL; MONONUCLEAR PHAGOCYTE; NONHUMAN; OXIDATIVE STRESS; PHAGOCYTOSIS; PNEUMONIA; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; PROTEIN CONTENT; RAT; THERAPY EFFECT; THP-1 CELL LINE; TRANSMISSION ELECTRON MICROSCOPY; UMBILICAL CORD; WESTERN BLOTTING; ANIMAL; COMPLICATION; CYTOLOGY; IMMUNOLOGY; MESENCHYMAL STEM CELL; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

ACUTE LUNG INJURY; ANIMALS; ESCHERICHIA COLI INFECTIONS; EXTRACELLULAR VESICLES; HUMANS; INTERFERON-GAMMA; MACROPHAGES; MALE; MESENCHYMAL STEM CELLS; PHAGOCYTOSIS; RATS; RATS, SPRAGUE-DAWLEY; UMBILICAL CORD;

EID: 85064992627     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/ALN.0000000000002655     Document Type: Article

References (47)

1. Bellani G, Laffey JG, Pham T, Fan E, Brochard L, Esteban A, Gattinoni L, van Haren F, Larsson A, McAuley DF, Ranieri M, Rubenfeld G, Thompson BT, Wrigge H, Slutsky AS, Pesenti A: Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries. J Am Med Assoc 2016; 315: 788-800
2. Curley GF, Jerkic M, Dixon S, Hogan G, Masterson C, O'Toole D, Devaney J, Laffey JG: Cryopreserved, xeno-free human umbilical cord mesenchymal stromal cells reduce lung injury severity and bacterial burden in rodent Escherichia coli-induced acute respiratory distress syndrome. Crit Care Med 2017; 45:e202-12
3. Curley GF, Hayes M, Ansari B, Shaw G, Ryan A, Barry F, O'Brien T, O'Toole D, Laffey JG: Mesenchymal stem cells enhance recovery and repair following ventilator-induced lung injury in the rat. Thorax 2012; 67:496-501
4. Curley GF, Ansari B, Hayes M, Devaney J, Masterson C, Ryan A, Barry F, O'Brien T, Toole DO, Laffey JG: Effects of intratracheal mesenchymal stromal cell therapy during recovery and resolution after ventilator-induced lung injury. Anesthesiology 2013; 118:924-32
5. Devaney J, Horie S, Masterson C, Elliman S, Barry F, O'Brien T, Curley GF, O'Toole D, Laffey JG: Human mesenchymal stromal cells decrease the severity of acute lung injury induced by E. coli in the rat. Thorax 2015; 70:625-35
6. Hayes M, Masterson C, Devaney J, Barry F, Elliman S, O'Brien T, O'Toole D, Curley GF, Laffey JG: Therapeutic efficacy of human mesenchymal stromal cells in the repair of established ventilator-induced lung injury in the rat. Anesthesiology 2015; 122:363-73
7. Krasnodembskaya A, Song Y, Fang X, Gupta N, Serikov V, Lee JW, Matthay MA: Antibacterial effect of human mesenchymal stem cells is mediated in part from secretion of the antimicrobial peptide LL-37. Stem Cells 2010; 28:2229-38
8. Jackson MV, Morrison TJ, Doherty DF, McAuley DF, Matthay MA, Kissenpfennig A, O'Kane CM, Krasnodembskaya AD: Mitochondrial transfer via tunneling nanotubes is an important mechanism by which mesenchymal stem cells enhance macrophage phagocytosis in the in vitro and in vivo models of ARDS. Stem Cells 2016; 34:2210-23
9. Keane C, Jerkic M, Laffey JG: Stem cell-based therapies for sepsis. Anesthesiology 2017; 127:1017-34
10. Laffey JG, Misak C, Kavanagh BP: Acute respiratory distress syndrome. BMJ 2017; 359:j5055
11. Lotvall J, Hill AF, Hochberg F, Buzas EI, Di Vizio D, Gardiner C, Gho YS, Kurochkin IV, Mathivanan S, Quesenberry P, Sahoo S, Tahara H, Wauben MH, Witwer KW, Thery C: Minimal experimental requirements for definition of extracellular vesicles and their functions: A position statement from the International Society for Extracellular Vesicles. J Extracell Vesicles 2014; 3:26913
12. Timmers L, Lim SK, Hoefer IE, Arslan F, Lai RC, van Oorschot AA, Goumans MJ, Strijder C, Sze SK, Choo A, Piek JJ, Doevendans PA, Pasterkamp G, de Kleijn DP: Human mesenchymal stem cell-conditioned medium improves cardiac function following myocardial infarction. Stem Cell Res 2011; 6:206-14
13. Zhang G, Zou X, Huang Y, Wang F, Miao S, Liu G, Chen M, Zhu Y: Mesenchymal stromal cell-derived extracellular vesicles protect against acute kidney injury through anti-oxidation by enhancing Nrf2/ ARE activation in rats. Kidney Blood Press Res 2016; 41:119-28
14. Haga H, Yan IK, Borelli DA, Matsuda A, Parasramka M, Shukla N, Lee DD, Patel T: Extracellular vesicles from bone marrow-derived mesenchymal stem cells protect against murine hepatic ischemia/reperfusion injury. Liver Transpl 2017; 23:791-803
15. Monsel A, Zhu YG, Gennai S, Hao Q, Hu S, Rouby JJ, Rosenzwajg M, Matthay MA, Lee JW: Therapeutic effects of human mesenchymal stem cell-derived microvesicles in severe pneumonia in mice. Am J Respir Crit Care Med 2015; 192:324-36
16. Najar M, Krayem M, Meuleman N, Bron D, Lagneaux L: Mesenchymal stromal cells and toll-like receptor priming: A critical review. Immune Netw 2017; 17:89-102
17. English K, Barry FP, Field-Corbett CP, Mahon BP: IFN-gamma and TNF-alpha differentially regulate immunomodulation by murine mesenchymal stem cells. Immunol Lett 2007; 110:91-100
18. Guess AJ, Daneault B, Wang R, Bradbury H, La Perle KMD, Fitch J, Hedrick SL, Hamelberg E, Astbury C, White P, Overolt K, Rangarajan H, Abu-Arja R, Devine SM, Otsuru S, Dominici M, O'Donnell L, Horwitz EM: Safety profile of good manufacturing practice manufactured interferon γ-primed mesenchymal stem/stromal cells for clinical trials. Stem Cells Transl Med 2017; 6:1868-79
19. Xu G, Guo Y, Seng Z, Cui G, Qu J: Bone marrow-derived mesenchymal stem cells co-expressing interleukin-18 and interferon-β exhibit potent antitumor effect against intracranial glioma in rats. Oncol Rep 2015; 34:1915-22
20. Di Lorenzo A, Lin MI, Murata T, Landskroner-Eiger S, Schleicher M, Kothiya M, Iwakiri Y, Yu J, Huang PL, Sessa WC: eNOS-derived nitric oxide regulates endothelial barrier function through VE-cadherin and Rho GTPases. J Cell Sci 2013; 126(Pt 24):5541-52
21. Wu F, Szczepaniak WS, Shiva S, Liu H, Wang Y, Wang L, Wang Y, Kelley EE, Chen AF, Gladwin MT, McVerry BJ: Nox2-dependent glutathionylation of endothelial NOS leads to uncoupled superoxide production and endothelial barrier dysfunction in acute lung injury. Am J Physiol Lung Cell Mol Physiol 2014; 307:L987-97
22. Shao M, Tang ST, Liu B, Zhu HQ: Rac1 mediates HMGB1-induced hyperpermeability in pulmonary microvascular endothelial cells via MAPK signal transduction. Mol Med Rep 2016; 13:529-35
23. Varkouhi A, Ormesher L, Jerkic M, Rabani R, Dos Santos C, Laffey JG, Curley GF: Therapeutic efficacy of human umbilical cord mesenchymal stem cell-derived extracellular vesicles in pre-clinical model of acute respiratory distress syndrome. Am J Respir Crit Care Med 2017; 195: A7503
24. Aldo PB, Craveiro V, Guller S, Mor G: Effect of culture conditions on the phenotype of THP-1 monocyte cell line. Am J Reprod Immunol 2013; 70:80-6
25. Chinnadurai R, Copland IB, Patel SR, Galipeau J: IDO-independent suppression of T cell effector function by IFN-γ-licensed human mesenchymal stromal cells. J Immunol 2014; 192:1491-501
26. Phinney DG, Di Giuseppe M, Njah J, Sala E, Shiva S, St Croix CM, Stolz DB, Watkins SC, Di YP, Leikauf GD, Kolls J, Riches DW, Deiuliis G, Kaminski N, Boregowda SV, McKenna DH, Ortiz LA: Mesenchymal stem cells use extracellular vesicles to outsource mitophagy and shuttle microRNAs. Nat Commun 2015; 6:8472
27. Angeloni NL, McMahon KM, Swaminathan S, Plebanek MP, Osman I, Volpert OV, Thaxton CS: Pathways for modulating exosome lipids identified by high-density lipoprotein-like nanoparticle binding to scavenger receptor type B-1. Sci Rep 2016; 6:22915
28. Chan T, Gu F: Development of acolorimetric, superparamagnetic biosensor for the capture and detection of biomolecules. Biosens Bioelectron 2013; 42:12-6
29. Devaney J, Curley GF, Hayes M, Masterson C, Ansari B, O'Brien T, O'Toole D, Laffey JG: Inhibition of pulmonary nuclear factor kappa-B decreases the severity of acute Escherichia coli pneumonia but worsens prolonged pneumonia. Crit Care 2013; 17:R82
30. Rabani R, Volchuk A, Jerkic M, Ormesher L, Garces-Ramirez L, Canton J, Masterson C, Gagnon S, Tatham KC, Marshall J, Grinstein S, Laffey JG, Szaszi K, Curley GF: Mesenchymal stem cells enhance NOX2 dependent ROS production and bacterial killing in macrophages during sepsis. Eur Respir J 2018; 51: pii: 1702021
31. Yu B, Zhang X, Li X: Exosomes derived from mesenchymal stem cells. Int J Mol Sci 2014; 15:4142-57
32. Pospichalova V, Svoboda J, Dave Z, Kotrbova A, Kaiser K, Klemova D, Ilkovics L, Hampl A, Crha I, Jandakova E, Minar L, Weinberger V, Bryja V: Simplified protocol for flow cytometry analysis of fluorescently labeled exosomes and microvesicles using dedicated flow cytometer. J Extracell Vesicles 2015; 4:25530
33. Cosenza S, Toupet K, Maumus M, Luz-Crawford P, Blanc-Brude O, Jorgensen C, Noel D: Mesenchymal stem cells-derived exosomes are more immunosuppressive than microparticles in inflammatory arthritis. Theranostics 2018; 8:1399-410
34. Wang XL, Zhao YY, Sun L, Shi Y, Li ZQ, Zhao XD, Xu CG, Ji HG, Wang M, Xu WR, Zhu W: Exosomes derived from human umbilical cord mesenchymal stem cells improve myocardial repair via upregulation of Smad7. Int J Mol Med 2018; 41:3063-72
35. Chen J, Li C, Chen L: The role of microvesicles derived from mesenchymal stem cells in lung diseases. Biomed Res Int 2015; 2015:985814
36. Zhu YG, Feng XM, Abbott J, Fang XH, Hao Q, Monsel A, Qu JM, Matthay MA, Lee JW: Human mesenchymal stem cell microvesicles for treatment of Escherichia coli endotoxin-induced acute lung injury in mice. Stem Cells 2014; 32:116-25
37. Henao Agudelo JS, Braga TT, Amano MT, Cenedeze MA, Cavinato RA, Peixoto-Santos AR, Muscara MN, Teixeira SA, Cruz MC, Castoldi A, Sinigaglia-Coimbra R, Pacheco-Silva A, de Almeida DC, Camara NOS: Mesenchymal stromal cell-derived microvesicles regulate an internal pro-inflammatory program in activated macrophages. Front Immunol 2017; 8:881
38. Lo Sicco C, Reverberi D, Balbi C, Ulivi V, Principi E, Pascucci L, Becherini P, Bosco MC, Varesio L, Franzin C, Pozzobon M, Cancedda R, Tasso R: Mesenchymal stem cell-derived extracellular vesicles as mediators of anti-inflammatory effects: Endorsement of macrophage polarization. Stem Cells Transl Med 2017; 6:1018-28
39. Ti D, Hao H, Tong C, Liu J, Dong L, Zheng J, Zhao Y, Liu H, Fu X, Han W: LPS-preconditioned mesenchymal stromal cells modify macrophage polarization for resolution of chronic inflammation via exosome-shuttled let-7b. J Transl Med 2015; 13:308
40. Li X, Liu L, Yang J, Yu Y, Chai J, Wang L, Ma L, Yin H: Exosome derived from human umbilical cord mesenchymal stem cell mediates MiR-181c attenuating burn-induced excessive inflammation. EBioMedicine 2016; 8:72-82
41. Sivanathan KN, Gronthos S, Rojas-Canales D, Thierry B, Coates PT: Interferon-gamma modification of mesenchymal stem cells: Implications of autologous and allogeneic mesenchymal stem cell therapy in allotransplantation. Stem Cell Rev 2014; 10:351-75
42. Soni S, Wilson MR, O'Dea KP, Yoshida M, Katbeh U, Woods SJ, Takata M: Alveolar macrophage-derived microvesicles mediate acute lung injury. Thorax 2016; 71:1020-9
43. van der Vliet A, Eiserich JP, Cross CE: Nitric oxide: A pro-inflammatory mediator in lung disease? Respir Res 2000; 1:67-72
44. Gao P, Yang X, Mungur L, Kampo S, Wen Q: Adipose tissue-derived stem cells attenuate acute lung injury through eNOS and eNOS-derived NO. Int J Mol Med 2013; 31:1313-8
45. Premer C, Blum A, Bellio MA, Schulman IH, Hurwitz BE, Parker M, Dermarkarian CR, DiFede DL, Balkan W, Khan A, Hare JM: Allogeneic mesenchymal stem cells restore endothelial function in heart failure by stimulating endothelial progenitor cells. EBioMedicine 2015; 2:467-75
46. Monsel A, Zhu YG, Gudapati V, Lim H, Lee JW: Mesenchymal stem cell derived secretome and extracellular vesicles for acute lung injury and other inflammatory lung diseases. Expert Opin Biol Ther 2016; 16:859-71
47. Bucci M, Roviezzo F, Posadas I, Yu J, Parente L, Sessa WC, Ignarro LJ, Cirino G: Endothelial nitric oxide synthase activation is critical for vascular leakage during acute inflammation in vivo. Proc Natl Acad Sci U S A 2005; 102:904-8